Viewing nowCombinationDiodipin Tablet 10/160 mg
Valsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.

MFDS item code 201600179 · Approved 2016.01.08 · Insurance code 656004090
Improvement of blood pressure control in essential hypertension
In cases where blood pressure is not well controlled due to essential hypertension, the combination of amlodipine and valsartan helps effectively lower and control blood pressure. These two medications cause vasodilation and stabilize blood pressure through different mechanisms, thus enhancing the treatment effect when monotherapy is insufficient. Therefore, this medication is used for the control of blood pressure in essential hypertension.
The recommended dose of this medication is 1 tablet once daily, taken with water regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). For patients with mild to moderate renal impairment, dose adjustment is not necessary; however, it is not administered to patients with severe renal impairment or those on dialysis. In patients with liver impairment, the daily dose of valsartan should not exceed 80 mg, and it is not administered to patients with severe liver impairment.
Safety and efficacy for pediatric patients under 18 years of age have not been established; therefore, the administration of this drug is not recommended.
This medicine can cause serious harm to the fetus and newborn during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Additionally, individuals with allergies to this medication, pregnant or nursing women, patients with severe kidney or liver diseases, and those with specific heart conditions should avoid taking this medication. Patients with sodium or fluid deficiency are at risk of hypotension, so their condition should be carefully checked before use, and immediate action should be taken if hypotensive symptoms occur during treatment. Patients with high potassium levels or those taking medications that may increase potassium levels should have their potassium levels monitored regularly. Patients with vascular problems in the kidneys or those who have recently undergone kidney transplants may be affected in terms of kidney function when taking this medication and should exercise caution. If symptoms of angioedema occur, discontinue use immediately and do not resume. Patients with heart failure or post-myocardial infarction should carefully monitor changes in kidney function while using this medication. Various side effects such as dizziness, headache, swelling, and hypotension may occur, so patients are advised to consult a physician if any unusual symptoms appear. Caution should be exercised as dizziness or fatigue may occur when driving or operating machinery. This medication may interact with other antihypertensives, potassium supplements, certain diuretics, specific antibiotics, and grapefruit juice, so it is essential to inform healthcare providers of any other medications being taken. It is safest for women who are pregnant or planning to become pregnant, as well as nursing mothers, to avoid using this medication. Safety and efficacy have not been sufficiently established for children under 18 years of age, so its use is not recommended. In cases of overdose, severe hypotension or cardiac dysfunction may occur, resulting in the need for immediate medical attention, and regular monitoring of blood pressure and kidney function during treatment is advised.
Urticaria, severe swelling (edema), angioedema, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, difficulty breathing or shortness of breath, asthma attacks, cough with fever and respiratory symptoms, jaundice (yellowing of the skin or eyes), severe lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that protects it from air and moisture, preferably at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain its effectiveness and ensure safe use.
Bright yellow, oval film-coated tablet
PTP packaging - 28 tablets/PTP [14 tablets/PTP x 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.